Vimarsana
Biggest News Aggregation in the World

Page 5 - Peterh Griffith News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Peterh Griffith. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Peterh Griffith Today - Breaking & Trending Today

Amgen To Present At The 2021 Piper Sandler Healthcare Conference - Vimarsana News

Amgen To Present At The 2021 Piper Sandler Healthcare Conference

/PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the 2021 Piper Sandler Healthcare Conference at 1:00 p.m. ET on Wednesday, Dec. 1, 2021. Murdo Gordon,...

Amgen To Present At The 2021 Piper Sandler Healthcare Conference - Vimarsana News

Amgen To Present At The 2021 Piper Sandler Healthcare Conference

/PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the 2021 Piper Sandler Healthcare Conference at 1:00 p.m. ET on Wednesday, Dec. 1, 2021. Murdo Gordon,...

Amgen : To Present At The Goldman Sachs 42nd Annual Global Healthcare Conference - Vimarsana News

Amgen : To Present At The Goldman Sachs 42nd Annual Global Healthcare Conference

THOUSAND OAKS, Calif., June 4, 2021 /PRNewswire/ -- Amgen will present at the Goldman Sachs 42nd Annual Global Healthcare Conference at 4:40 p.m. ET on Wednesday, June 9, 2021. David M. Reese,... | June 4, 2021

Amgen To Present At The Goldman Sachs 42nd Annual Global Healthcare Conference - Vimarsana News

Amgen To Present At The Goldman Sachs 42nd Annual Global Healthcare Conference

Amgen To Present At The Goldman Sachs 42nd Annual Global Healthcare Conference News provided by Share this article Share this article THOUSAND OAKS, Calif., June 4, 2021 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the Goldman Sachs 42nd Annual Global Healthcare Conference at 4:40 p.m. ET on Wednesday, June 9, 2021. David M. Reese, M.D., executive vice president of Research and Development and Peter H. Griffith, executive vice president and chief financial officer at Amgen will present at the conference. Live audio of the conference call will be broadcast over the internet simultaneou...

Amgen and Kyowa Kirin to Jointly Develop and Commercialize KHK4083, a Phase 3-Ready, Potential First-In-Class Treatment for Atopic Dermatitis - Vimarsana News

Amgen and Kyowa Kirin to Jointly Develop and Commercialize KHK4083, a Phase 3-Ready, Potential First-In-Class Treatment for Atopic Dermatitis

/PRNewswire/ -- Amgen (NASDAQ: AMGN) and Kyowa Kirin Co., Ltd. (TSE: 4151) today announced an agreement to jointly develop and commercialize KHK4083, which is...